These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 33803926)

  • 1. Comparing the Safety and Efficacy of Microwave Ablation Using Thermosphere
    Kuroda H; Nagasawa T; Fujiwara Y; Sato H; Abe T; Kooka Y; Endo K; Oikawa T; Sawara K; Takikawa Y
    Cancers (Basel); 2021 Mar; 13(6):. PubMed ID: 33803926
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hepatic resection versus operative microwave ablation for single hepatocellular carcinoma ≤5 cm: A propensity score-matched analysis.
    Ryu T; Takami Y; Wada Y; Hara T; Sasaki S; Saitsu H
    Surgery; 2019 Sep; 166(3):254-262. PubMed ID: 31279438
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Percutaneous microwave and radiofrequency ablation for hepatocellular carcinoma: a retrospective comparative study.
    Lu MD; Xu HX; Xie XY; Yin XY; Chen JW; Kuang M; Xu ZF; Liu GJ; Zheng YL
    J Gastroenterol; 2005 Nov; 40(11):1054-60. PubMed ID: 16322950
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Microwave vs radiofrequency ablation for hepatocellular carcinoma within the Milan criteria: a propensity score analysis.
    Liu W; Zheng Y; He W; Zou R; Qiu J; Shen J; Yang Z; Zhang Y; Wang C; Wang Y; Zuo D; Li B; Yuan Y
    Aliment Pharmacol Ther; 2018 Sep; 48(6):671-681. PubMed ID: 30063081
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy of microwave ablation versus radiofrequency ablation for the treatment of hepatocellular carcinoma in patients with chronic liver disease: a randomised controlled phase 2 trial.
    Vietti Violi N; Duran R; Guiu B; Cercueil JP; Aubé C; Digklia A; Pache I; Deltenre P; Knebel JF; Denys A
    Lancet Gastroenterol Hepatol; 2018 May; 3(5):317-325. PubMed ID: 29503247
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Radiofrequency Ablation and Microwave Ablation in Liver Tumors: An Update.
    Izzo F; Granata V; Grassi R; Fusco R; Palaia R; Delrio P; Carrafiello G; Azoulay D; Petrillo A; Curley SA
    Oncologist; 2019 Oct; 24(10):e990-e1005. PubMed ID: 31217342
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Radiofrequency ablation vs. surgery for perivascular hepatocellular carcinoma: Propensity score analyses of long-term outcomes.
    Lee S; Kang TW; Cha DI; Song KD; Lee MW; Rhim H; Lim HK; Sinn DH; Kim JM; Kim K
    J Hepatol; 2018 Jul; 69(1):70-78. PubMed ID: 29524532
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Microwave ablation versus sorafenib for intermediate-Stage Hepatocellular carcinoma with transcatheter arterial chemoembolization refractoriness: a propensity score matching analysis.
    Chen S; Shi M; Shen L; Qi H; Wan W; Cao F; Xie L; Wu Y; Chen G; Mo J; Zhu G; Ye D; Zhang Y; Feng Z; Xu L; Fan W
    Int J Hyperthermia; 2020; 37(1):384-391. PubMed ID: 32323585
    [No Abstract]   [Full Text] [Related]  

  • 9. Local recurrence after microwave thermosphere ablation of malignant liver tumors: results of a surgical series.
    Takahashi H; Kahramangil B; Berber E
    Surgery; 2018 Apr; 163(4):709-713. PubMed ID: 29273176
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparisons of recurrence-free survival and overall survival between microwave versus radiofrequency ablation treatment for hepatocellular carcinoma: A multiple centers retrospective cohort study with propensity score matching.
    Du S; Yang JZ; Chen J; Zhou WG; Sun YY
    PLoS One; 2020; 15(1):e0227242. PubMed ID: 31918433
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Small Hepatocellular Carcinoma: Radiofrequency Ablation versus Nonanatomic Resection--Propensity Score Analyses of Long-term Outcomes.
    Kang TW; Kim JM; Rhim H; Lee MW; Kim YS; Lim HK; Choi D; Song KD; Kwon CH; Joh JW; Paik SW; Paik YH; Ahn JH
    Radiology; 2015 Jun; 275(3):908-19. PubMed ID: 25688888
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Efficacy of microwave ablation in treatment of hepatocellular carcinoma within the Milan criteria: a report of 696 cases].
    Wang YM; Qian GJ; Xu Y; Wang N; Sheng YH
    Zhonghua Gan Zang Bing Za Zhi; 2017 May; 25(5):344-348. PubMed ID: 28763840
    [No Abstract]   [Full Text] [Related]  

  • 13. Management of people with early- or very early-stage hepatocellular carcinoma: an attempted network meta-analysis.
    Majumdar A; Roccarina D; Thorburn D; Davidson BR; Tsochatzis E; Gurusamy KS
    Cochrane Database Syst Rev; 2017 Mar; 3(3):CD011650. PubMed ID: 28351116
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Radiofrequency ablation vs. microwave ablation for patients with benign thyroid nodules: a propensity score matching study.
    Yue WW; Wang SR; Lu F; Sun LP; Guo LH; Zhang YL; Li XL; Xu HX
    Endocrine; 2017 Feb; 55(2):485-495. PubMed ID: 27905049
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Radiofrequency ablation versus repeat resection for recurrent hepatocellular carcinoma (≤ 5 cm) after initial curative resection.
    Feng Y; Wu H; Huang DQ; Xu C; Zheng H; Maeda M; Zhao X; Wang L; Xiao F; Lv H; Liu T; Qi J; Li J; Zhong N; Wang C; Feng H; Liang B; Ren W; Qin C; Nguyen MH; Zhu Q
    Eur Radiol; 2020 Nov; 30(11):6357-6368. PubMed ID: 32529568
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transarterial Chemoembolization Combined with Either Radiofrequency or Microwave Ablation in Management of Hepatocellular Carcinoma.
    Abdelaziz AO; Abdelmaksoud AH; Nabeel MM; Shousha HI; Cordie AA; Mahmoud ShH; Medhat E; Omran D; Elbaz TM
    Asian Pac J Cancer Prev; 2017 Jan; 18(1):189-194. PubMed ID: 28240516
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 3D visualization ablation planning system assisted microwave ablation for hepatocellular carcinoma (Diameter >3): a precise clinical application.
    An C; Li X; Zhang M; Yang J; Cheng Z; Yu X; Han Z; Liu F; Dong L; Yu J; Liang P
    BMC Cancer; 2020 Jan; 20(1):44. PubMed ID: 31959147
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Surgical Resection Versus Radiofrequency Ablation for Single Hepatocellular Carcinoma ≤ 2  cm in a Propensity Score Model.
    Liu PH; Hsu CY; Hsia CY; Lee YH; Huang YH; Chiou YY; Lin HC; Huo TI
    Ann Surg; 2016 Mar; 263(3):538-45. PubMed ID: 25775062
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Conventional Chemoembolization Plus Radiofrequency Ablation versus Surgical Resection for Single, Medium-Sized Hepatocellular Carcinoma: Propensity-Score Matching Analysis.
    Lee HJ; Kim JW; Hur YH; Cho SB; Lee BC; Lee BK; Hwang EC; Cho YS; Seon HJ
    J Vasc Interv Radiol; 2019 Mar; 30(3):284-292.e1. PubMed ID: 30819467
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Combined Therapy of Transcatheter Arterial Chemoembolization and Radiofrequency Ablation versus Surgical Resection for Single 2-3 cm Hepatocellular Carcinoma: A Propensity-Score Matching Analysis.
    Lee HJ; Kim JW; Hur YH; Shin SS; Heo SH; Cho SB; Kang YJ; Lim HS; Seon HJ; Jeong YY
    J Vasc Interv Radiol; 2017 Sep; 28(9):1240-1247.e3. PubMed ID: 28688816
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.